ஆஸ்திரேலிய மையம் க்கு நோய் ப்ரிப்யாரெட்நெஸ் இல் கீலாஂக் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

CSIRO A ‘warm’ COVID-19 vaccine suitable for remote and resource-limited locations lacking access to cold storage supply chains is one step closer following an international collaboration between scientists from India and Australia. CSIRO, Australia’s national science agency, played an important role in evaluating heat-tolerant COVID-19 vaccine formulations developed by the Indian Institute of Science (IISc) and biotech start-up Mynvax – against all current SARS-CoV-2 variants of concern. Published today in the peer-reviewed ACS Infectious Diseases journal, researchers showed the vaccine formulations triggered a strong immune response in mice, protected hamsters from the virus, and remained stable at 37°C up to a month and at 100°C for up to 90 minutes.

New south walesRob grenfellMynvax privateIndian institute of science iiscGates foundationAustralian centre for disease preparedness in geelongIndustrial research organisationIndian instituteAustralian centreDisease preparednessBiosecurity directorFederal departmentCommonwealth scientificInovio pharmaceuticalQuacquarelli symondsMynvax private limited